Thursday 19 September 2024

Pharma & Biotech Start-up & Scale-up News

Featured

A clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases.
Pharmaceutical
Lexicon's sotagliflozin shows promise in glucose control
12 September 2024
Pharmaceutical
New data analysis shows benefit of Lexicon’s sotagliflozin
4 September 2024

Latest Ones To Watch News

Biotechnology
NanoVation inks genetic medicines deal with Novo Nordisk
18 September 2024
Pharmaceutical
Organon to acquire Dermavant in back-loaded deal
18 September 2024
Biotechnology
Promising signs for MAIA’s telomere-targeting treatment
18 September 2024
More ones to watch news >
Reset all filters
Refine Search
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics
Reunion Neuroscience
Atopia Therapeutics
Prologue Medicines
Lykos Therapeutics
Attovia Therapeutics
Ajax Therapeutics
Cartesian Therapeutics
AltruBio
Progentos Therapeutics
Aktis Oncology


Today's issue

Biotechnology
First FDA nod for Keytruda in MPM
18 September 2024
Biotechnology
NanoVation inks genetic medicines deal with Novo Nordisk
18 September 2024
Pharmaceutical
Organon to acquire Dermavant in back-loaded deal
18 September 2024
Pharmaceutical
Novartis’ Kisqali cleared for expanded indication by FDA
18 September 2024
Biotechnology
Promising signs for MAIA’s telomere-targeting treatment
18 September 2024
Pharmaceutical
Novo Nordisk CEO to face Senate questions amid pricing controversy
18 September 2024
Pharmaceutical
Athira shifts focus to ALS drug after Alzheimer’s flop
18 September 2024

Company Spotlight

A clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases.




Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze